Torsten Malmström
Chief Tech/Sci/R&D Officer at CAMURUS AB
Net worth: 3 M $ as of 2024-06-29
Profile
Torsten Malmström is currently the Chief Technical Officer at Camurus AB.
Previously, he worked as the Director-Pharmaceutical Development at Zealand Pharma A, the Development Director at PolyPeptide Laboratories (Sweden) AB, and the Team Manager at AstraZeneca AB.
Dr. Malmström holds a doctorate degree from the University of Lund.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CAMURUS AB
0.08% | 2024-05-13 | 45,363 ( 0.08% ) | 3 M $ | 2024-06-29 |
Torsten Malmström active positions
| Companies | Position | Start |
|---|---|---|
| CAMURUS AB | Chief Tech/Sci/R&D Officer | 2012-12-31 |
Former positions of Torsten Malmström
| Companies | Position | End |
|---|---|---|
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
PolyPeptide Laboratories (Sweden) AB
 PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology PolyPeptide Laboratories (Sweden) AB specializes in the production of proprietary peptides. The firm manufactures polypeptide, custom peptide Synthesis, peptide synthesis, and generic peptide. Its peptides products are part of several different pharmaceutical products. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Corporate Officer/Principal | - |
Training of Torsten Malmström
| University of Lund | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CAMURUS AB | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| Private companies | 2 |
|---|---|
PolyPeptide Laboratories (Sweden) AB
PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology PolyPeptide Laboratories (Sweden) AB specializes in the production of proprietary peptides. The firm manufactures polypeptide, custom peptide Synthesis, peptide synthesis, and generic peptide. Its peptides products are part of several different pharmaceutical products. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Torsten Malmström
